World leader in probiotic products
BioGaia is an innovative Swedish healthcare company and has been a world-leader in food supplements with probiotics for more than 30 years. Over the years we have created networks of leading, independent researchers and specialists, manufacturing experts and local distribution partners worldwide. Our products are recommended by pediatricians and other healthcare professionals in more than 100 countries.
BioGaia’s products contain Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri), a probiotic bacteria that helps good microorganisms restore a natural balance in the gut. L. reuteri is one of few bacteria that has co-evolved with humans and because of this it naturally colonizes and has a strong adaptation and interacts with us. To date L. reuteri has been tested in 224 clinical trials (May 2020) and proven effective and safe in children and adults.
BioGaia wants to contribute to better health in the world by offering clinically-proven and user-friendly probiotic products.
Contact us Our products
Investors
BioGaia’s class B share are listed on the Mid Cap segment of the Nasdaq OMX Nordic Stockholm exchange. Read more
Our business model
Thanks to a successful business model, BioGaia has been able to grow globally with a lean, efficient and agile organization. BioGaia’s business model is based on three external networks – research, production and distribution. Read more
Distribution network
BioGaia's products are sold through around 80 local distribution partners in 100 countries around the world.
Read more
BioGaia's history
BioGaia´s history goes back to the 1980´s, at the time when HIV was discovered. The two scientists Sven Lindgren and Walt Dobrogosz were investigating different probiotics in order to see what effects they had in this area. Read more
Read more
Probiotic supplements
BioGaia's products are sold through around 80 local distribution partners in 100 countries around the world.
Read more
Our research
To date, 224 clinical studies using BioGaia’s human strains of L. reuteri have been performed on 18,000 individuals of all ages. (May 2020)
Read more
Sustainability
We have a clear strategy and have set the goals and priorities for 2019. Our sustainability initiatives have been given structure and a long-term approach.
Read more